CAM
OGEN icon

Chesapeake Asset Management’s Oragenics OGEN Stock Holding History

Chesapeake Asset Management’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed – – 371
2025
Q4 		$0 Hold
1
– – ﹤0.01% 387
2025
Q3 		$1 Hold
1
– – ﹤0.01% 323
2025
Q2 		$3 Buy
+1
New +$5 ﹤0.01% 321
2025
Q1 		– Hold
0
– – – 586
2024
Q4 		– Hold
0
– – – 527
2024
Q3 		– Hold
0
– – – 525
2024
Q2 		– Hold
0
– – – 336
2024
Q1 		– Hold
0
– – – 327
2023
Q4 		– Hold
0
– – – 376
2023
Q3 		– Hold
0
– – – 436
2023
Q2 		– Hold
0
– – – 436
2023
Q1 		– Hold
0
– – – 420

Other funds holding OGEN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
AAS
Ameritas Advisory Services Lincoln, Nebraska $4.96B AUM 27.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SJIM
St. Johns Investment Management Jacksonville, Florida $264M AUM 29.48% 1-Year Est. Return

Chesapeake Asset Management's OGEN Position: Q1 2026 in Review

Chesapeake Asset Management sold out of Oragenics (OGEN) in Q1 2026, closing a stake of 1 share.

Chesapeake Asset Management first reported a position in OGEN in Q2 2025 and held it in 3 quarters. The position peaked at $3 in Q2 2025. 20 funds tracked by Wall St. Rank hold OGEN as of Q1 2026.

  • Chesapeake Asset Management reported no remaining Oragenics position as of Q1 2026 after selling out during the quarter.
  • Chesapeake Asset Management sold 1 Oragenics share in Q1 2026.
  • Chesapeake Asset Management first reported a position in Oragenics in Q2 2025 and held it in 3 quarters.
  • Chesapeake Asset Management's Oragenics position peaked at $3 in Q2 2025.
  • 20 funds tracked by Wall St. Rank held Oragenics as of Q1 2026.

Based on Chesapeake Asset Management's 13F filing for Q1 2026, filed 12 May 2026.